Loading...
Please wait while we prepare your content
Please wait while we prepare your content
Cancer care stands at a critical juncture—traditional approaches have reached their limits against an ever-adapting enemy. This book reveals how artificial intelligence is transforming every aspect of oncology, from early detection to personalized treatments, creating hope where there was despair through powerful human-machine partnerships.

Recognized leaders in cancer care share their perspectives on this groundbreaking work
Featuring endorsements from ASCO leadership, major cancer institutes, and clinical innovators
Chief Executive Officer
American Society of Clinical Oncology (ASCO)
Dr. Flora's 'Rebooting Cancer Care' is a timely and pragmatic exploration of AI's transformative potential in oncology. He moves beyond the hype to offer a clear-eyed view of how these powerful tools can enhance our ability to deliver high-quality, evidence-based care that, most importantly, is humanistic and patient-centered. This book is an important contribution to the ongoing dialogue - both within and beyond healthcare - about how we can best harness technology to improve the lives of our patients.
Executive Vice President, Chief Health Policy Officer
Texas Oncology
Dr. Flora's Rebooting Cancer Care is a must read. Doug's passion to share the vision of how AI will transform the cancer ecosystem will help leaders consider how to make the changes necessary to evolve. Thank you for shining light on the path ahead of us.
Vice President, AI & Medical Informatics, Hematologist & Medical Oncologist
Tempus
Dr. Douglas Flora is the rare trifecta—an accomplished cancer leader, a dynamic, compassion-first communicator, and a multi-cancer survivor whose lived experience sharpens his vision for how AI can truly humanize oncology. As Executive Medical Director and endowed chair at St. Elizabeth Healthcare's Yung Family Cancer Center, he has built programs that pair precision medicine with real-world care delivery; as Editor-in-Chief of AI in Precision Oncology (2025), he convenes a broad network of clinicians, scientists, policymakers, and technologists—and channels that "collective intelligence" into pragmatic advances from imaging and pathology AI to trial matching and MCED/MRD adoption. His survivor perspective is not a footnote but the through-line of his leadership—he writes and speaks openly about sitting in the waiting rooms himself, and it's why audiences consistently find him both passionate and deeply reassuring. On a personal note: Doug is a mentor and friend who has materially shaped my own voice in AI and oncology; his counsel—and the reach of his national network—has elevated my thought leadership and the impact of my work. If cancer is the boss battle, Doug is the teammate who brings the map, the med-kit, and—somehow—the Wi-Fi.
Chief Executive Officer
Parker Institute for Cancer Immunotherapy
Dr. Flora is a leading voice to envision how artificial intelligence can meaningfully advance cancer care in the real world. His work underscores how AI is reshaping every part of the continuum, from discovery science to clinical implementation, and how these innovations can reach patients faster and more equitably. 'Rebooting Cancer Care' reflects his deep expertise and his unwavering commitment to improving outcomes for every patient.
Join our exclusive list and be among the first to access upcoming opportunities, signed copies, special notices, and more.
Opportunities for signed copies
Bulk order information and discounts
Special notices and exclusive content
Updates on new editions and formats
“Doug Flora captures with clarity and compassion what many of us in oncology have long felt—that the future of cancer care depends not only on scientific breakthroughs but also on rethinking how we deliver empathy, technology, and access at scale.”
“Doug Flora has become the north star for AI in Oncology—not because he sought to lead, but because he chose to elevate. His vision isn't just about technology; it's about transformation.”
“Rarely does a book forge such a unique visionary bridge between AI and oncology.”
A leading voice in the integration of artificial intelligence with cancer care, bringing together deep medical expertise with cutting-edge technology understanding. With extensive experience in oncolo...

Additional retailers coming soon